share_log

盘中速览 | 港股再度走弱,科指跌近2%;科网股、医药股跌幅居前,中远海能逆市涨近5%

Intraday quick overview | Hong Kong stocks weakened again, with the Codex falling nearly 2%; Science and Technology Network stocks and pharmaceutical stocks had the highest declines, and COSCO Haineng rose nearly 5% against the market

Futu News ·  Sep 21, 2023 10:37

Futu News reported on September 21 that the three major Hong Kong stock indices weakened again. As of press release, the Hang Seng Index fell 1.12%, the Codex fell 1.66%, and the National Index fell 1.06%.

On the sector side, SciNet stocks generally declinedKuaishou fell nearly 4%, Meituan and Bilibili fell about 3%, NetEase, Tencent, and Ali fell about 2%, and Baidu and Xiaomi fell more than 1%.

Pharmaceutical stocks weakenLepu Biotech fell nearly 11%, BeiGene fell nearly 6%, Pharmacom fell nearly 4%, and Pharmaceutical Kangde fell more than 1%.

Sporting goods stocks weaken, Xtep and Li Ning fell nearly 3%, Anta fell more than 2%, and Taobo fell slightly.

Beer stocks fall, Bailida Group fell nearly 5%, China Resources Brewery and Budweiser Asia Pacific fell nearly 3%, and Tsingtao Brewery fell nearly 2%.

$COSCO SHIP ENGY (01138.HK)$A rise of nearly 5% led shipping stocks. Short-term disturbances did not change the logic of the oil transportation boom cycle, and the fundamentals of supply and demand were still strong.

$BEKE-W (02423.HK)$An increase of nearly 4%. Guangzhou's optimization of the property market purchase restriction policy will help promote the circulation of second-hand housing.

$XPENG-W (09868.HK)$It continues to fall by more than 5%, and the price of the new G9 has been drastically reduced. The market is worried that its gross margin will be dragged down.

edit/ruby

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment